Correlation Between Ascendis Pharma and A1LN34
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and A1LN34 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and A1LN34 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and A1LN34, you can compare the effects of market volatilities on Ascendis Pharma and A1LN34 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of A1LN34. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and A1LN34.
Diversification Opportunities for Ascendis Pharma and A1LN34
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ascendis and A1LN34 is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and A1LN34 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on A1LN34 and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with A1LN34. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of A1LN34 has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and A1LN34 go up and down completely randomly.
Pair Corralation between Ascendis Pharma and A1LN34
Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 1.46 times more return on investment than A1LN34. However, Ascendis Pharma is 1.46 times more volatile than A1LN34. It trades about 0.18 of its potential returns per unit of risk. A1LN34 is currently generating about 0.03 per unit of risk. If you would invest 4,884 in Ascendis Pharma AS on September 24, 2024 and sell it today you would earn a total of 451.00 from holding Ascendis Pharma AS or generate 9.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ascendis Pharma AS vs. A1LN34
Performance |
Timeline |
Ascendis Pharma AS |
A1LN34 |
Ascendis Pharma and A1LN34 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ascendis Pharma and A1LN34
The main advantage of trading using opposite Ascendis Pharma and A1LN34 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, A1LN34 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in A1LN34 will offset losses from the drop in A1LN34's long position.Ascendis Pharma vs. Novo Nordisk AS | Ascendis Pharma vs. Vertex Pharmaceuticals Incorporated | Ascendis Pharma vs. Moderna | Ascendis Pharma vs. BIONTECH SE DRN |
A1LN34 vs. Novo Nordisk AS | A1LN34 vs. Vertex Pharmaceuticals Incorporated | A1LN34 vs. Moderna | A1LN34 vs. BIONTECH SE DRN |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |